Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion related macular oedema : A prospective randomized comparison—Response
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Clinical & Experimental Ophthalmology - 47(2019), 5, Seite 687-687 |
Beteiligte Personen: |
Macky, Tamer A. [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
© 2019 Royal Australian and New Zealand College of Ophthalmologists |
---|
Umfang: |
1 |
---|
doi: |
10.1111/ceo.13490 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY003371603 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY003371603 | ||
003 | DE-627 | ||
005 | 20230307125255.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230213s2019 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/ceo.13490 |2 doi | |
028 | 5 | 2 | |a CEO_CEO13490.xml |
035 | |a (DE-627)WLY003371603 | ||
035 | |a (WILEY)CEO13490 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.95 |2 bkl | ||
100 | 1 | |a Macky, Tamer A. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion related macular oedema |b A prospective randomized comparison—Response |
264 | 1 | |c 2019 | |
300 | |a 1 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2019 Royal Australian and New Zealand College of Ophthalmologists | ||
700 | 1 | |a Gado, Ahmed S. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical & Experimental Ophthalmology |g 47(2019), 5, Seite 687-687 |w (DE-627)WLY003370127 |x 14429071 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2019 |g number:5 |g pages:687-687 |g extent:1 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
936 | b | k | |a 44.95 |q ASE |
951 | |a AR | ||
952 | |d 47 |j 2019 |e 5 |h 687-687 |g 1 |